A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists

Outros usuários também visualizaram estes artigos

Sacubitril/valsartan: A practical guide Cândida Fonseca, Dulce Brito, Jorge Ferreira, Fátima Franco, João Morais, José Silva Cardoso

10.1016/j.repc.2018.10.008

Sacubitril/valsartan: A practical guide revisited Cândida Fonseca, Dulce Brito, Jorge Ferreira, Fátima Franco, João Morais, José Silva Cardoso

10.1016/j.repc.2019.05.007

Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction Martin Negreira-Caamaño, Jorge Martínez-Del Río, Alfonso Morón-Alguacil, Pedro Pérez-Díaz, Jesus Piqueras-Flores

10.1016/j.repc.2022.12.008